Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program ("Cardiolotse") in Germany.
Adherence
Cardiovascular disease
Care management
Discharge
Hospitalization
Socioeconomics
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
21 Oct 2024
21 Oct 2024
Historique:
received:
03
07
2024
accepted:
08
10
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
20
10
2024
Statut:
epublish
Résumé
We conducted a prospective, randomized, controlled, two-group parallel trial investigating the effectiveness of a care management program employing cardiac care navigators providing post-discharge support to patients compared to standard care. The intervention commenced in 2019/2020 for 2862 patients hospitalized with heart failure, coronary heart disease, or cardiac arrhythmias in departments of cardiology across eight participating sites of a hospital group in Berlin, Germany. We analyzed the results using an intention-to-treat approach. The primary outcome was the all-cause rehospitalization rate after 12 months. Secondary outcomes included rehospitalizations due to one of the qualifying cardiac diagnoses, duration of rehospitalization, mortality, health-related quality of life, and several process indicators. Trial data were collected from a combination of face-to-face and phone interviews conducted by hospital staff throughout the 12-month follow-up period using standardized questionnaires. Administrative claims data were provided by a large statutory health insurer. Outcomes for the intervention and control groups were compared using logistic regression, generalized linear models (GLMs) with a negative binomial distribution, ordinary least squares, and Cox proportional hazards regression. Compared to the control group (N = 1294), the intervention group (N = 1256) had a lower rate of all-cause rehospitalizations (62.6% vs. 66.4%, p = 0.05) and shorter lengths of stay (14.49 vs. 16.89 days, p = 0.02) during the 12-month follow-up period. These differences were also present for rehospitalizations due to the cardiac diseases qualifying for study recruitment, with rehospitalization rates for the intervention and control groups being 58.0% vs. 61.4% (p = 0.08) and particularly pronounced for lengths of rehospitalization stay of 12.97 vs. 15.40 days (p = 0.01), respectively. Subgroup analyses indicated positive effects of the intervention for patients 70 years and older (p = 0.05), females (p = 0.06), and those with little or no German language proficiency (p = 0.03). Furthermore, we found positive effects on patients' adherence to health-related behavioral recommendations (81.91% vs. 73.95%, p = 0.000). This study adds to the body of evidence indicating that care management interventions supporting patients as they transition from the inpatient to the outpatient sector can lower rehospitalizations, decrease length of rehospitalization stays, and improve adherence to post-discharge recommendations. German Clinical Trial Register, DRKS00020424 . Registered 2020-06-18. (retrospectively registered).
Sections du résumé
BACKGROUND
BACKGROUND
We conducted a prospective, randomized, controlled, two-group parallel trial investigating the effectiveness of a care management program employing cardiac care navigators providing post-discharge support to patients compared to standard care.
METHODS
METHODS
The intervention commenced in 2019/2020 for 2862 patients hospitalized with heart failure, coronary heart disease, or cardiac arrhythmias in departments of cardiology across eight participating sites of a hospital group in Berlin, Germany. We analyzed the results using an intention-to-treat approach. The primary outcome was the all-cause rehospitalization rate after 12 months. Secondary outcomes included rehospitalizations due to one of the qualifying cardiac diagnoses, duration of rehospitalization, mortality, health-related quality of life, and several process indicators. Trial data were collected from a combination of face-to-face and phone interviews conducted by hospital staff throughout the 12-month follow-up period using standardized questionnaires. Administrative claims data were provided by a large statutory health insurer. Outcomes for the intervention and control groups were compared using logistic regression, generalized linear models (GLMs) with a negative binomial distribution, ordinary least squares, and Cox proportional hazards regression.
RESULTS
RESULTS
Compared to the control group (N = 1294), the intervention group (N = 1256) had a lower rate of all-cause rehospitalizations (62.6% vs. 66.4%, p = 0.05) and shorter lengths of stay (14.49 vs. 16.89 days, p = 0.02) during the 12-month follow-up period. These differences were also present for rehospitalizations due to the cardiac diseases qualifying for study recruitment, with rehospitalization rates for the intervention and control groups being 58.0% vs. 61.4% (p = 0.08) and particularly pronounced for lengths of rehospitalization stay of 12.97 vs. 15.40 days (p = 0.01), respectively. Subgroup analyses indicated positive effects of the intervention for patients 70 years and older (p = 0.05), females (p = 0.06), and those with little or no German language proficiency (p = 0.03). Furthermore, we found positive effects on patients' adherence to health-related behavioral recommendations (81.91% vs. 73.95%, p = 0.000).
CONCLUSIONS
CONCLUSIONS
This study adds to the body of evidence indicating that care management interventions supporting patients as they transition from the inpatient to the outpatient sector can lower rehospitalizations, decrease length of rehospitalization stays, and improve adherence to post-discharge recommendations.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trial Register, DRKS00020424 . Registered 2020-06-18. (retrospectively registered).
Identifiants
pubmed: 39428539
doi: 10.1186/s12916-024-03691-7
pii: 10.1186/s12916-024-03691-7
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
480Informations de copyright
© 2024. The Author(s).
Références
WHO. Fact sheet: Cardiovascular diseases (CVDs). 2023. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) . Accessed 28 July 2023.
Tarride J-E, Lim M, DesMeules M, et al. A review of the cost of cardiovascular disease. Can J Cardiol. 2009;25(6):e195-202.
doi: 10.1016/S0828-282X(09)70098-4
pubmed: 19536390
pmcid: 2722492
Health Systems Innovation Lab. The state of cardiovascular disease in G20+ countries. 2022. https://www.hsph.harvard.edu/health-systems-innovation-lab/2022/05/11/cvd-g20/ . Accessed 01 Sept 2023.
Komalasari R, Nurjanah, Yoche MM. Quality of life of people with cardiovascular disease: a descriptive study. Asian Pac Isl Nurs J. 2019;4(2):92–6.
doi: 10.31372/20190402.1045
pubmed: 31259235
pmcid: 6571918
Busse R, Blümel M, Knieps F, et al. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390(10097):882–97.
doi: 10.1016/S0140-6736(17)31280-1
pubmed: 28684025
SVR. Gutachten 2018: Bedarfsgerechte Steuerung der Gesundheitsversorgung. 2018. https://www.svr-gesundheit.de/fileadmin/Gutachten/Gutachten_2018/Gutachten_2018.pdf . Accessed 16 Sept 2024.
Jepma P, ter Riet G, van Rijn M, et al. Readmission and mortality in patients ≥70 years with acute myocardial infarction or heart failure in the Netherlands: a retrospective cohort study of incidences and changes in risk factors over time. Neth Heart J. 2019;27(3):134–41.
doi: 10.1007/s12471-019-1227-4
pubmed: 30715672
pmcid: 6393584
Huynh QL, Saito M, Blizzard CL, et al. Roles of nonclinical and clinical data in prediction of 30-day rehospitalization or death among heart failure patients. J Cardiac Fail. 2015;21(5):374–81.
doi: 10.1016/j.cardfail.2015.02.002
Al Shamsi H, Almutairi AG, Al Mashrafi S, et al. Implications of language barriers for healthcare: a systematic review. Oman Med J. 2020;35(2):e122.
doi: 10.5001/omj.2020.40
pubmed: 32411417
pmcid: 7201401
Braeseke G, Huster S, Pflug C, et al. Studie zum Versorgungsmanagement durch Patientenlotsen. 2018. https://www.bundesgesundheitsministerium.de/service/publikationen/details/studie-zum-versorgungsmanagement-durch-patientenlotsen.html . Accessed 01 Sept 2023.
Hendricks V, Schmidt S, Vogt A, et al. Case management program for patients with chronic heart failure: effectiveness in terms of mortality, hospital admissions and costs. Dtsch Arztebl Int. 2014;111(15):264–70.
pubmed: 24776611
pmcid: 4004935
Peters-Klimm F, Campbell S, Hermann K, et al. Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial. Trials. 2010;11:56.
doi: 10.1186/1745-6215-11-56
pubmed: 20478035
pmcid: 2882359
Stokes J, Kristensen SR, Checkland K, et al. Effectiveness of multidisciplinary team case management: difference-indifferences analysis. BMJ Open. 2016;6:e010468.
doi: 10.1136/bmjopen-2015-010468
pubmed: 27084278
pmcid: 4838740
BMG. Mitglieder und Versicherte der GKV. 2023. https://www.bundesgesundheitsministerium.de/themen/krankenversicherung/zahlen-und-fakten-zur-krankenversicherung/mitglieder-und-versicherte.html . Accessed 01 Sept 2023.
Geiger I, Reber KC, Darius H, et al. Improving care coordination for patients with cardiac disease: study protocol of the randomised controlled new healthcare programme (Cardiolotse). Contemp Clin Trials. 2021;103:106297.
doi: 10.1016/j.cct.2021.106297
pubmed: 33515786
EuroQol. EQ-5D-5L | EuroQol. 2023. https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-5l/ . Accessed 07 June 2024.
Cho KH, Lee SG, Jun B, et al. Effects of continuity of care on hospital admission in patients with type 2 diabetes: analysis of nationwide insurance data. BMC Health Serv Res. 2015;15:107.
doi: 10.1186/s12913-015-0745-z
pubmed: 25879858
pmcid: 4393878
Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.
doi: 10.1093/aje/kwq433
pubmed: 21330339
Faria R, Gomes M, Epstein D, et al. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32(12):1157–70.
doi: 10.1007/s40273-014-0193-3
pubmed: 25069632
pmcid: 4244574
Del Corral T, Fabero-Garrido R, Plaza-Manzano G, et al. Minimal clinically important differences in EQ-5D-5L index and VAS after a respiratory muscle training program in individuals experiencing long-term post-COVID-19 symptoms. Biomedicines. 2023;11(9):2522.
doi: 10.3390/biomedicines11092522
pubmed: 37760964
pmcid: 10526144
Coretti S, Ruggeri M, McNamee P. The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res. 2014;14(2):221–33.
doi: 10.1586/14737167.2014.894462
pubmed: 24625040
Xu H, Farmer HR, Granger BB, et al. Perceived versus actual risks of 30-day readmission in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2021;14(1):e006586.
doi: 10.1161/CIRCOUTCOMES.120.006586
pubmed: 33430612
pmcid: 7855013
Ziaeian B, Fonarow GC. The prevention of hospital readmissions in heart failure. Prog Cardiovasc Dis. 2016;58(4):379–85.
doi: 10.1016/j.pcad.2015.09.004
pubmed: 26432556
WHO. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020. World Health Organization, 27 August 2020. 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1 . Accessed 01 Sept 2023.
Whaley CM, Pera MF, Cantor J, et al. Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw Open. 2020;3(11):e2024984.
doi: 10.1001/jamanetworkopen.2020.24984
pubmed: 33151319
pmcid: 7645698
Mauro V, Lorenzo M, Paolo C, et al. Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases. Intern Emerg Med. 2020;15(5):787–90.
doi: 10.1007/s11739-020-02395-z
pubmed: 32519136
pmcid: 7282471
Muschol J, Gissel C. COVID-19 pandemic and waiting times in outpatient specialist care in Germany: an empirical analysis. BMC Health Serv Res. 2021;21(1):1076.
doi: 10.1186/s12913-021-07094-9
pubmed: 34635091
pmcid: 8503703